Skip to main content
Hematopoietic and Lymphatic System NeoplasmDigital healthBehavioral

What this study is

This clinical trial assesses whether resource identification for primary caregivers can affect financial stress, quality of life, depression, and the general belief in the ability to cope with daily life. Caregivers of patients receiving cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CS+HIPEC) demonstrate that they endure high depressive symptom burdens and financial distress. Further, they experience symptom trajectories that differ from those of patients. In short, they require differential timing of supportive interventions. This study aims to reduce financial toxicity and distress levels and to increase self-efficacy, satisfaction and engagement with care. Information gathered from this study may help researchers determine whether telehealth interventions for caregivers may increase awareness of recommended resources that could be beneficial during caregivers journey.

What's being tested

  • Telemedicine

    Intervention · OTHER

    Receive telehealth navigation intervention

  • Survey administration

    Intervention · OTHER

  • Electronic health record review

    Intervention · OTHER

  • Best Practice

    Intervention · OTHER

    Receive standard caregiving experience

Both Survey administration and Electronic health record review

Ancillary studies

Study details

Official title
Telehealth Intervention to Address Distress and Financial Toxicity in the Care Partners of Patients Receiving Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
Sponsor
Wake Forest University Health Sciences
Conditions
Hematopoietic and Lymphatic System Neoplasm · Malignant Solid Neoplasm
Enrolling
50 people
Starts
2025-01-31
Est. completion
2026-12
Design
Open-label, randomized, parallel groups
Record
View on ClinicalTrials.gov ↗